Nektar Therapeutics | NKTR - Capital De Empréstimo

Preço das Ações
77.50
Mudança Diária
-0.35 -0.45%
Mensal
5.69%
Anual
736.44%
Q2 Previsão
75.38




Capital De Empréstimo Alterar Data
Agios Pharmaceuticals USD 1.06M 0 2022-09
ALKERMES USD 285.82M 639K 2024-09
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
Amgen USD 50B 2.43B 2025-12
Baxter International USD 9.47B 726M 2025-12
BioCryst Pharmaceuticals USD 428.67M 234.31M 2025-12
Biogen USD 6.29B 1.4M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Cara Therapeutics USD 0 0 2025-03
Cipla INR 2.98B 454.6M 2025-09
Dr.Reddys Laboratories INR 11.61B 29M 2025-12
Eisai JPY 134.77B 12M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Grifols EUR 9.95B 722.93M 2025-12
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
Incyte USD 30.2M 5.17M 2025-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
MacroGenics USD 70M 256K 2025-12
Merck USD 39.97B 6B 2025-09
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
Roche Holding CHF 27.43B 966M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Takeda JPY 4.27T 81.29B 2025-12
Teva Pharmaceutical Industries USD 14.99B 1.78B 2025-12
Xencor USD 76.48M 11.29M 2025-12